Cytolab switches cervical screening to Techcyte SureView

Cytolab in Karlsruhe has moved its cervical cytology screening to Techcyte SureView, completing a shift from BD FocalPoint to a digital, AI-assisted workflow. The lab says the change has improved throughput and established a routine model that other laboratories in Europe can evaluate.

Why it matters: - Cytolab's move shows a working transition from a traditional cervical cytology workflow to a digital, AI-assisted model in daily routine use. - The switch matters for labs that want faster screening, browser-based review, and a more standardized process for cervical cancer detection. - Techcyte SureView is now being used in routine screening at one of the first laboratories in Europe to adopt the platform for daily use.

What happened: - Cytolab in Karlsruhe, Germany, transitioned its cervical cytology screening to Techcyte SureView. - The laboratory has been running routine screening on the digital workflow since January 2026. - Cytolab previously screened on BD FocalPoint. - The transition was announced August 6, 2026. - Installation, training, and onboarding were delivered with Waters Advanced Diagnostics, the exclusive worldwide distributor of Techcyte SureView.

The details: - Cytolab specializes in the early detection of gynecologic cancers and their precursors and has done so since 1968. - The laboratory screens cervical cytology samples referred by office-based practices in the region and beyond. - Slides are scanned on site on an Evident Spectral HT2 scanner. - Images are uploaded to the Techcyte platform and reviewed in a standard web browser. - SureView presents relevant images and annotates cells and organisms of interest. - Cytologists then assess the case and sign it out. - Cytolab currently runs Waters SurePath preparations. - Cytolab plans to add Hologic ThinPrep. - Dr. med. Julia Boländer said screeners became comfortable with the software and scanner quickly after training and are getting through daily work faster. - Techcyte says SureView is CE-marked under the IVDD in Europe, with IVDR in progress. - In the United States, SureView is for Research Use Only.

Between the lines: - The transition is not just a software change. It also changes how the laboratory team works from slide scanning to case review and sign-out. - Cytolab's early adoption gives Techcyte and Waters Advanced Diagnostics a live reference point for other laboratories in the region. - Techcyte Europe director Troy Bankhead said the team's direct feedback helped the workflow improve under real daily volume. - Waters Advanced Diagnostics product manager Sandra Knoethig said the move provides a concrete example for other labs considering a similar shift.

What's next: - Cytolab plans to expand the workflow by adding Hologic ThinPrep. - Techcyte and Waters Advanced Diagnostics are likely to use Cytolab as a proof point for additional European laboratory conversions. - The longer-term regulatory path for SureView in Europe continues with IVDR progress.

The bottom line: - Cytolab's switch gives Techcyte a real-world European installation to point to as digital cervical cytology workflows gain traction.